Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training

International Journal of Sports Medicine

Volumn 18, Issue 4, 1997, Pages 238-241

  Roelen, C A M ^a   De Vries, W R ^b   Koppeschaar, H P F ^a   Vervoorn, C ^b   Thijssen, J H H ^a   Blankenstein, M A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Endurance training; GHBP; IGF I

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ADULT; AEROBIC CAPACITY; ARTICLE; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCATCHARD PLOT; TRAINING;

ADULT; ANAEROBIC THRESHOLD; ANALYSIS OF VARIANCE; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GEL; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; HEART RATE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LACTATES; MALE; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PHYSICAL EDUCATION AND TRAINING; PHYSICAL ENDURANCE; RADIOIMMUNOASSAY; WORK CAPACITY EVALUATION;

EID: 0030792486     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-972626     Document Type: Article

References (28)

1. Arslanian S. A., Menon R. K., Gierl A. P., Heil B. V., Foley T. P.: Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type 1 diabetes. Diab Med 10: 833-838, 1993.
2. Baumann G., Stolar M. W., Amburn K., Barsano C. P., DeVries B. C.: A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62: 134-141, 1986.
3. Baumann G., Shaw M. A., Amburn K.: Circulating growth hormone binding proteins. J Clin Invest 17: 67-81, 1994.
4. Daughaday W. H., Trivedi B., Andrews B. A.: The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development. J Clin Endocrinol Metab 65: 1072-1074, 1987.
5. Davenport M. L., Svoboda M. E., Koerber K. L., Van Wijk J. J., Clemmons D. R., Underwood L. E.: Serum concentrations of IGF-II are not changed by short term fasting and refeeding. J Clin Endocrinol Metab 67: 1231-1236, 1988.
6. Davila N., Alcaniz J., Salto L., Estrada J., Barcelo B., Baumann G.: Serum growth hormone-binding protein is unchanged in adult panhypopituitarism. J Clin Endocrinol Metab 79: 1347-1350, 1994.
7. Durnin J. V. G. A., Womersly J.: Body fat assessed from total body density and its estimation from skinfold thickness. Br J Nutr 32: 77-97, 1974.
8. Furlanetto R. W., Underwood L. E., Van Wijk J. J., d'Ercole A. J.: Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60: 121-132, 1977.
9. Hagberg J. M., Seals D. R., Yerg J. E., Gavin J., Gingerich R., Premachandra B., Holloszy J. O.: Metabolic responses to exercise in young and older athletes and sedentary men. J Appl Physiol 65: 900-908, 1982.
10. Heck H., Mader A., Hess G., Mucke S., Muller R., Hollmann W.: Justification of the 4mmol/l lactate threshold. Int J Sports Med 6: 117-130, 1985.
11. Hollmann W., Hettinger T.: Sportmedizin - Arbeits- und Trainingsgrundlagen. Stuttgart - New York, Schattauer Verlag, 1976, pp 445-451.
12. Herington A. C., Ymer S. I., Stevenson J. L.: Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77: 1817-1823, 1986.
13. Ho K. K. Y., Hoffman D. M., O'Sullivan A. J., Johnston C., Valiontis E.: Different modes of growth hormone (GH) administration do not change GH binding protein activity in man. Clin Endocrinol (Oxf) 38: 143-148, 1993.
14. Hochberg Z., Barkey R. J., Even L., Peleg I., Youdim M. B. H., Amit T.: The effect of human growth hormone therapy on GH binding protein in GH deficient children. Acta Endocrinol (Copenh) 125: 23-27, 1991.
15. Jahreis G., Kauf E., Frohner G., Schmidt H. E.: Influence of intensive exercise on insulin-like growth factor 1, thyroid and steroid hormones in female gymnasts. Growth Regul 1: 95-99, 1991.
16. Kelly P. J., Eisman J. A., Stuart M. C., Pocock N. A., Sambrook P. N., Gwinn T. H.: Somatomedin-C, physical fitness and bone density. J Clin Endocrinol Metab 70: 718-723, 1990.
17. Leung D. W., Spencer S. A., Cachianes G., Hammonds R. G., Collins C., Henzel W. J., Barnard R., Waters W. J., Wood W. I.: Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330: 537-543, 1987.
18. Martha P. M., Reiter E. O., Davila N., Shaw M. A., Holcombe J. H., Baumann G.: Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. J Clin Endocrinol Metab 75: 1464-1469, 1992.
19. Massa G., Igout A., Rombauts L., Frankenne F., Vanderschueren-Lodeweyckx M.: Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women. Clin Endocrinol 39: 569-575, 1993.
20. Miell J. P., Taylor A. M., Zini M., Maheshwari H. G., Moss R. J. M., Valcavi R.: Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 76: 950-955, 1993.
21. Poehlman E. T., Copeland K. C.: Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab 71: 1468-1473, 1990.
22. Postel-Vinay M.C., Tar A., Hocquette J.F., Clot J.P., Fontoura M., Brauner R., Rappaport R.: Human plasma growth hormone (GH)-binding proteins are regulated by GH and testosterone. J Clin Endocrinol Metab 73: 197-202, 1991.
23. Rajkovic I. A., Valiontis E., Ho K. K. Y.: Direct quantitation of growth hormone-binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods. J Clin Endocrinol Metab 78: 772-777, 1994.
24. Roelen C. A. M., Donker G. H., Thijssen J. H. H., Blankenstein M. A.: A method for measuring the binding affinity and capacity of high affinity growth hormone binding protein using FPLC to separate bound and free ligand. J Liquid Chromatogr 15: 1259-1275, 1992.
25. Smith W. C., Kuniyoshi J., Thalamantes F.: Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains. Mol Endocrinol 3: 984-988, 1989.
26. Tauber M., De Bouet du Portal H., Sallerin-Caute B., Rochiccioli P., Bastide R.: Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 76: 1135-1139, 1993.
27. Tigranian R. A., Kalita N. F., Davydova N. A., Dorokhova B. R., Malakhov M. G., Melkonian A. G., Roganov A. S., Stalnaya I. D., Chernikhovskaya T. I., Shumilina T. N.: Observations on the Soviet/Canadian transpolar ski trek: status of selected hormones and biologically active compounds. Med Sport Sci 33: 106-138, 1992.
28. Weltman A., Weltman J. Y., Schurrer R., Evans W. S., Veldhuis J. D., Rogol A. D.: Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J Appl Physiol 72: 2188-2196, 1992.